{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:40:45Z","timestamp":1793040045156,"version":"4.5.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UIDB\/00100\/2020"],"award-info":[{"award-number":["UIDB\/00100\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bcp.2025.117048","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:08:53Z","timestamp":1749236933000},"page":"117048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Targeting MRSA penicillin-binding protein 2a: structural insights, allosteric mechanisms, and the potential of adjuvant inhibitors"],"prefix":"10.1016","volume":"239","author":[{"given":"Pedro C.","family":"Rosado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Matilde","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-4738","authenticated-orcid":false,"given":"Gon\u00e7alo C.","family":"Justino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117048_b0005","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-060614-034516","article-title":"Mechanisms of methicillin resistance in Staphylococcus aureus","volume":"84","author":"Peacock","year":"2015","journal-title":"Annu. Rev. Biochem"},{"issue":"3","key":"10.1016\/j.bcp.2025.117048_b0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pro.3737","article-title":"Constructing and deconstructing the bacterial cell wall","volume":"29","author":"Fisher","year":"2020","journal-title":"Protein Sci."},{"issue":"9","key":"10.1016\/j.bcp.2025.117048_b0015","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00863-17","article-title":"\u03b2-Lactam antibiotics with a high affinity for PBP2 act synergistically with the FtsZ-Targeting agent TXA707 against methicillin-resistant Staphylococcus aureus","volume":"61","author":"Ferrer-Gonz\u00e1lez","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bcp.2025.117048_b0020","first-page":"870","article-title":"Structural basis for the \u03b2 lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus","volume":"9","author":"Lim","year":"2002","journal-title":"Nat. Struct. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0025","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","article-title":"Antibiotic resistance and the MRSA problem","volume":"7","author":"Vestergaard","year":"2019","journal-title":"Microbiol Spectr."},{"issue":"42","key":"10.1016\/j.bcp.2025.117048_b0030","doi-asserted-by":"crossref","first-page":"16808","DOI":"10.1073\/pnas.1300118110","article-title":"How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function","volume":"110","author":"Otero","year":"2013","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.bcp.2025.117048_b0035","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/iub.1289","article-title":"Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus","volume":"66","author":"Fishovitz","year":"2014","journal-title":"IUBMB Life"},{"issue":"6","key":"10.1016\/j.bcp.2025.117048_b0040","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/acs.chemrev.0c01010","article-title":"\u03b2-lactams against the fortress of the gram-positive Staphylococcus aureus bacterium","volume":"121","author":"Fisher","year":"2021","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0045","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-micro-041222-125931","article-title":"Cell growth and division of Staphylococcus aureus","volume":"78","author":"Pinho","year":"2024","journal-title":"Annu. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117048_b0050","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1021\/acschembio.2c00741","article-title":"Coupling novel probes with molecular localization microscopy reveals cell wall homeostatic mechanisms in Staphylococcus aureus","volume":"17","author":"Lund","year":"2022","journal-title":"ACS Chem. Biol."},{"issue":"16","key":"10.1016\/j.bcp.2025.117048_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/JB.00204-21","article-title":"Impact of FtsZ inhibition on the localization of the penicillin binding proteins in methicillin-resistant Staphylococcus aureus","volume":"203","author":"Ferrer-Gonzalez","year":"2021","journal-title":"J. Bacteriol."},{"issue":"6721","key":"10.1016\/j.bcp.2025.117048_b0060","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1126\/science.adn1369","article-title":"Two codependent routes lead to high-level MRSA","volume":"386","author":"Adedeji-Olulana","year":"2024","journal-title":"Science"},{"issue":"6721","key":"10.1016\/j.bcp.2025.117048_b0065","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1126\/science.adt0042","article-title":"Bacteria divide to conquer antibiotics","volume":"386","author":"Harrison","year":"2024","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.bcp.2025.117048_b0070","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s00018-008-7591-7","article-title":"Substrate specificity of bacterial DD-peptidases (penicillin-binding proteins)","volume":"65","author":"Pratt","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0075","article-title":"Glycosyltransferases and transpeptidases\/penicillin-binding proteins: valuable targets for new antibacterials","volume":"5","author":"Sauvage","year":"2016","journal-title":"Antibiotics (basel)"},{"issue":"13","key":"10.1016\/j.bcp.2025.117048_b0080","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1073\/pnas.0701160104","article-title":"Crystal structure of a peptidoglycan glycosyltransferase suggests a model for processive glycan chain synthesis","volume":"104","author":"Yuan","year":"2007","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.bcp.2025.117048_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ph13110392","article-title":"Assembly of peptidoglycan fragments - a synthetic challenge","volume":"13","author":"Queda","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.bcp.2025.117048_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2014.05.031","article-title":"Peptidoglycan architecture of gram-positive bacteria by solid-state NMR","author":"Kim","year":"2015","journal-title":"BBA"},{"key":"10.1016\/j.bcp.2025.117048_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112312","article-title":"Penicillin binding protein 2a: an overview and a medicinal chemistry perspective","volume":"199","author":"Shalaby","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2025.117048_b0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.coph.2005.06.002","article-title":"\u03b2-lactams against methicillin-resistant Staphylococcus aureus","volume":"5","author":"Guignard","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117048_b0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.08.003","article-title":"Mechanisms of \u03b2-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria","volume":"78","author":"Tang","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.bcp.2025.117048_b0110","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1021\/jacs.6b12565","article-title":"Conformational dynamics in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus, allosteric communication network and enablement of catalysis","volume":"139","author":"Mahasenan","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.bcp.2025.117048_b0115","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/AAC.42.3.717","article-title":"Analysis of diversity of mutations in the mecI gene and mecA promoter\/operator region of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis","volume":"42","author":"Kobayashi","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2025.117048_b0120","doi-asserted-by":"crossref","unstructured":"S.R. Partridge, S.M. Kwong, N. Firth, S.O. Jensen, Mobile genetic elements associated with antimicrobial resistance. Clinical Microbiology Reviews. 2018;31(4):10.1128\/cmr.00088-17.","DOI":"10.1128\/CMR.00088-17"},{"issue":"17","key":"10.1016\/j.bcp.2025.117048_b0125","doi-asserted-by":"crossref","first-page":"17888","DOI":"10.1074\/jbc.M313123200","article-title":"On the transcriptional regulation of methicillin resistance: MecI repressor in complex with its operator","volume":"279","author":"Garcia-Castellanos","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2025.117048_b0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/jac\/47.3.297","article-title":"Detection of mecA, mecR1 and mecI genes among clinical isolates of methicillin-resistant staphylococci by combined polymerase chain reactions","volume":"47","author":"Petinaki","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3947\/ic.2013.45.2.117","article-title":"Genomic basis for methicillin resistance in Staphylococcus aureus","volume":"45","author":"Hiramatsu","year":"2013","journal-title":"Infect Chemother"},{"issue":"9","key":"10.1016\/j.bcp.2025.117048_b0140","article-title":"Molecular determinants of \u03b2-lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA): an updated review","volume":"12","author":"Lade","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"32","key":"10.1016\/j.bcp.2025.117048_b0145","doi-asserted-by":"crossref","first-page":"10870","DOI":"10.1074\/jbc.RA120.013029","article-title":"Structural analysis of avibactam-mediated activation of the bla and mec divergons in methicillin-resistant Staphylococcus aureus","volume":"295","author":"Alexander","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"7943","key":"10.1016\/j.bcp.2025.117048_b0150","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41586-022-05583-3","article-title":"Structural basis of broad-spectrum \u03b2-lactam resistance in Staphylococcus aureus","volume":"613","author":"Alexander","year":"2023","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117048_b0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.vetmic.2005.10.024","article-title":"Occurrence of methicillin-resistant Staphylococcus aureus strains from cattle and chicken, and analyses of their mecA, mecR1 and mecI genes","volume":"114","author":"Lee","year":"2006","journal-title":"Vet. Microbiol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0160","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/AAC.02045-13","article-title":"Role of the mecA gene in oxacillin resistance in a Staphylococcus aureus clinical strain with a pvl-positive ST59 genetic background","volume":"58","author":"Chen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2025.117048_b0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2180-11-76","article-title":"Evidence for a purifying selection acting on the \u03b2-lactamase locus in epidemic clones of methicillin-resistant Staphylococcus aureus","volume":"11","author":"Milheiri\u00e7o","year":"2011","journal-title":"BMC Microbiol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117048_b0170","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2217\/fmb.12.107","article-title":"Key genetic elements and regulation systems in methicillin-resistant Staphylococcus aureus","volume":"7","author":"Hao","year":"2012","journal-title":"Future Microbiol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117048_b0175","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/jac\/dkac107","article-title":"The bla and mec families of \u03b2-lactam resistance genes in the genera macrococcus, mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on macrococcus","volume":"77","author":"Schwendener","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-8244(03)00370-5","article-title":"Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones","volume":"40","author":"Aires de Sousa","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117048_b0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.meegid.2008.07.007","article-title":"The evolution of Staphylococcus aureus","volume":"8","author":"Deurenberg","year":"2008","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.bcp.2025.117048_b0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.micpath.2016.10.028","article-title":"Staphylococcal chromosomal cassettes mec (SCCmec): a mobile genetic element in methicillin-resistant Staphylococcus aureus","volume":"101","author":"Liu","year":"2016","journal-title":"Microb. Pathog."},{"issue":"29","key":"10.1016\/j.bcp.2025.117048_b0195","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1021\/jacs.7b04881","article-title":"Peptidoglycan cross-linking preferences of Staphylococcus aureus penicillin-binding proteins have implications for treating MRSA infections","volume":"139","author":"Srisuknimit","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.bcp.2025.117048_b0200","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1368-7646(98)80048-4","article-title":"Role of fem factors in methicillin resistance","volume":"1","author":"Berger-B\u00e4chi","year":"1998","journal-title":"Drug Resist. Updat."},{"issue":"11","key":"10.1016\/j.bcp.2025.117048_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048981","article-title":"The nonantibiotic small molecule cyslabdan enhances the potency of \u03b2-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis","volume":"7","author":"Koyama","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bcp.2025.117048_b0210","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4103\/0250-474X.174968","article-title":"Screening and toxicity analysis of catechin Isomers against FemA protein","volume":"77","author":"Singhal","year":"2015","journal-title":"Indian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12866-021-02257-4","article-title":"Regulation of virulence and \u03b2-lactamase gene expression in Staphylococcus aureus isolates: cooperation of two-component systems in bloodstream superbugs","volume":"21","author":"Dehbashi","year":"2021","journal-title":"BMC Microbiol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117048_b0220","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijmm.2016.05.008","article-title":"SigmaB regulates ccrAB expression and SCCmec excision in methicillin-resistant Staphylococcus aureus","volume":"306","author":"Zhang","year":"2016","journal-title":"Int. J. Med. Microbiol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117048_b0225","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/infdis\/jiw386","article-title":"The global regulon sarA regulates \u03b2-lactam antibiotic resistance in methicillin-resistant Staphylococcus aureus in vitro and in Endovascular infections","volume":"214","author":"Li","year":"2016","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0230","article-title":"The Secondary resistome of methicillin-resistant Staphylococcus aureus to \u03b2-lactam antibiotics","volume":"14","author":"Abdelmalek","year":"2025","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13568-020-01000-y","article-title":"Increased resistance of a methicillin-resistant Staphylococcus aureus \u0394agr mutant with modified control in fatty acid metabolism","volume":"10","author":"Song","year":"2020","journal-title":"AMB Express"},{"issue":"12","key":"10.1016\/j.bcp.2025.117048_b0240","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3390\/antibiotics11121714","article-title":"Study of SarA by DNA affinity capture assay (DACA) employing three promoters of key virulence and resistance genes in methicillin-resistant Staphylococcus aureus","volume":"11","author":"Kim","year":"2022","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.bcp.2025.117048_b0245","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2958.2003.03599.x","article-title":"Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus","volume":"49","author":"Kuroda","year":"2003","journal-title":"Mol. Microbiol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117048_b0250","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1128\/AAC.00356-06","article-title":"Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus","volume":"50","author":"Gardete","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.bcp.2025.117048_b0255","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1128\/AAC.00113-06","article-title":"Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus","volume":"50","author":"Renzoni","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.bcp.2025.117048_b0260","article-title":"The role of ArlRS and VraSR in regulating Ceftaroline hypersusceptibility in methicillin-resistant Staphylococcus aureus","volume":"10","author":"Villanueva","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0265","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1574-6976.2007.00098.x","article-title":"The different shapes of cocci","volume":"32","author":"Zapun","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"issue":"22","key":"10.1016\/j.bcp.2025.117048_b0270","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1007\/s00018-005-5148-6","article-title":"\u03b2-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome","volume":"62","author":"Fuda","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2025.117048_b0275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Helen","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcp.2025.117048_b0280","unstructured":"E. Lilkova, P. Petkov, N. Ilieva, L. Litov, \u200bThe PyMOL Molecular Graphics System (2015)."},{"issue":"5","key":"10.1016\/j.bcp.2025.117048_b0285","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02637-18","article-title":"The quinazolinone allosteric inhibitor of PBP 2a synergizes with Piperacillin and tazobactam against methicillin-resistant Staphylococcus aureus","volume":"63","author":"Janardhanan","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"14","key":"10.1016\/j.bcp.2025.117048_b0290","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2174\/0929867322666150311150215","article-title":"The allosteric site for the nascent cell wall in penicillin-binding protein 2a: an Achilles\u2019 heel of methicillin-resistant Staphylococcus aureus","volume":"22","author":"Acebr\u00f3n","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2025.117048_b0295","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ijch.202000012","article-title":"Molecular dynamics simulations of antibiotic Ceftaroline at the allosteric site of penicillin-binding protein 2a (PBP2a)","volume":"60","author":"Chiang","year":"2020","journal-title":"Isr. J. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2025.117048_b0300","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00895-23","article-title":"Unraveling the mechanism of ceftaroline-induced allosteric regulation in penicillin-binding protein 2a: insights for novel antibiotic development against methicillin-resistant Staphylococcus aureus","volume":"67","author":"Jiao","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0305","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08941939.2012.664099","article-title":"History of antibiotics. from salvarsan to cephalosporins","volume":"25","author":"Zaffiri","year":"2012","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.bcp.2025.117048_b0310","article-title":"Ceftaroline: A new cephalosporin with activity against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"3","author":"Duplessis","year":"2011","journal-title":"Clin. Med. Rev. Ther."},{"key":"10.1016\/j.bcp.2025.117048_b0315","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Sebastian","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.bcp.2025.117048_b0320","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1021\/jacs.5b00056","article-title":"Discovery of antibiotic (E)-3-(3-carboxyphenyl)-2-(4-cyanostyryl)quinazolin-4(3H)-one","volume":"137","author":"Bouley","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2025.117048_b0325","first-page":"3","article-title":"Mechanisms of action and antimicrobial activity of ceftobiprole","volume":"32","author":"Morosini","year":"2019","journal-title":"Rev. Esp. Quimioter."},{"key":"10.1016\/j.bcp.2025.117048_b0330","doi-asserted-by":"crossref","first-page":"32096","DOI":"10.1074\/jbc.M112.355644","article-title":"Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole","volume":"287","author":"Lovering","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2025.117048_b0335","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1128\/AAC.39.4.990","article-title":"Comparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria","volume":"39","author":"Malanoski","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bcp.2025.117048_b0340","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1021\/acs.accounts.0c00776","article-title":"Unconventional antibacterials and adjuvants","volume":"54","author":"Chang","year":"2021","journal-title":"Acc. Chem. Res."},{"issue":"20","key":"10.1016\/j.bcp.2025.117048_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28207008","article-title":"A review on five and six-membered heterocyclic compounds targeting the penicillin-binding protein 2 (PBP2A) of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"28","author":"Ambade","year":"2023","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bcp.2025.117048_b0350","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1039\/C2MD00251E","article-title":"Unprecedented inhibition of resistant penicillin binding proteins by bis-2-oxoazetidinylmacrocycles","volume":"3","author":"Sliwa","year":"2012","journal-title":"MedChemComm."},{"issue":"8","key":"10.1016\/j.bcp.2025.117048_b0355","article-title":"Non-\u03b2-lactam allosteric inhibitors target methicillin-resistant Staphylococcus aureus: an in silico drug discovery study","volume":"10","author":"Ibrahim","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bcp.2025.117048_b0360","article-title":"Synergistic inhibition mechanism of quinazolinone and piperacillin on penicillin-binding protein 2a: a promising approach for combating methicillin-resistant Staphylococcus aureus","volume":"1\u201313","author":"Jiao","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.bcp.2025.117048_b0365","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28104240","article-title":"Novel thiazolylketenyl quinazolinones as potential anti-MRSA agents and allosteric modulator for PBP2a","volume":"28","author":"Dai","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117048_b0370","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12906-015-0699-z","article-title":"Inhibition of penicillin-binding protein 2a (PBP2a) in methicillin resistant Staphylococcus aureus (MRSA) by combination of ampicillin and a bioactive fraction from Duabanga grandiflora","volume":"15","author":"Santiago","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"issue":"10","key":"10.1016\/j.bcp.2025.117048_b0375","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00127-21","article-title":"Cranberry-derived proanthocyanidins potentiate \u03b2-lactam antibiotics against resistant bacteria","volume":"87","author":"Gallique","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117048_b0380","doi-asserted-by":"crossref","DOI":"10.3390\/biom9040127","article-title":"Anti-lung cancer, and anti-bacterial activities of Toxicodendron vernicifluum","volume":"9","author":"Saravanakumar","year":"2019","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.bcp.2025.117048_b0385","article-title":"Flavonoids as potential anti-MRSA agents through modulation of PBP2a: a computational and experimental study","volume":"9","author":"Alhadrami","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.bcp.2025.117048_b0390","doi-asserted-by":"crossref","first-page":"109070","DOI":"10.1016\/j.compbiomed.2024.109070","article-title":"Retention of methicillin susceptibility in Staphylococcus aureus using natural adjuvant as an allosteric modifier of penicillin-binding protein 2a","volume":"181","author":"Islam","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bcp.2025.117048_b0395","doi-asserted-by":"crossref","DOI":"10.2174\/0115680266312143240805191718","article-title":"Unveiling the potential of Bergenia phenolics: Vitexin's role in allosteric modulation of PBP2a as a strategy against MRSA resistance","author":"Verma","year":"2024","journal-title":"Curr. Top. Med. Chem."},{"issue":"17","key":"10.1016\/j.bcp.2025.117048_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26175314","article-title":"Preliminary insight of pyrrolylated-chalcones as new anti-methicillin-resistant Staphylococcus aureus (anti-MRSA) agents","volume":"26","author":"Gunasekharan","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117048_b0405","doi-asserted-by":"crossref","first-page":"154073","DOI":"10.1016\/j.phymed.2022.154073","article-title":"Phytochemicals with activity against methicillin-resistant Staphylococcus aureus","volume":"100","author":"Liang","year":"2022","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0410","doi-asserted-by":"crossref","first-page":"73","DOI":"10.31083\/2019.8866","article-title":"Synthesis and antibacterial activity of novel icariin derivatives","volume":"74","author":"Wang","year":"2019","journal-title":"Pharmazie"},{"issue":"12","key":"10.1016\/j.bcp.2025.117048_b0415","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3390\/molecules22122245","article-title":"Synergy between ursolic and Oleanolic acids from Vitellaria paradoxa leaf Extract and \u03b2-lactams against methicillin-resistant Staphylococcus aureus: in vitro and in vivo activity and underlying mechanisms","volume":"22","author":"Catteau","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117048_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104676","article-title":"Inhibition of penicillin-binding protein 2a (PBP2a) in methicillin resistant Staphylococcus aureus (MRSA) by combination of oxacillin and a bioactive compound from Ramalinaroesleri","volume":"150","author":"Goel","year":"2021","journal-title":"Microb. Pathog."},{"issue":"50","key":"10.1016\/j.bcp.2025.117048_b0425","doi-asserted-by":"crossref","first-page":"50012","DOI":"10.1021\/acsomega.4c09518","article-title":"Antibacterial potential of ethyl 3,5-dibromoorsellinate, a derivative of diphenyl ethers from Graphis handelii, against methicillin-resistant Staphylococcus aureus","volume":"9","author":"Nguyen","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bcp.2025.117048_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114050","article-title":"An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a","volume":"229","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2025.117048_b0435","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00453-18","article-title":"Activities of oxadiazole antibacterials against Staphylococcus aureus and other gram-positive bacteria","volume":"62","author":"Ceballos","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2025.117048_b0440","doi-asserted-by":"crossref","first-page":"113442","DOI":"10.1016\/j.ejmech.2021.113442","article-title":"A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: structure-activity relationship studies","volume":"219","author":"Verma","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2025.117048_b0445","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70088","article-title":"Identification of potential PBP2a inhibitors against methicillin-resistant Staphylococcus aureus via drug repurposing and combination therapy","volume":"105","author":"Jiao","year":"2025","journal-title":"Chem. Biol. Drug Des."},{"issue":"9","key":"10.1016\/j.bcp.2025.117048_b0450","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41429-024-00747-x","article-title":"Anti-MRSA activity of chlorophenyl pyrrolo benzodiazepines compound","volume":"77","author":"Mondal","year":"2024","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"4","key":"10.1016\/j.bcp.2025.117048_b0455","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1021\/acsmedchemlett.5c00061","article-title":"From natural products to small molecules: recent advancements in anti-MRSA therapeutics","volume":"16","author":"Smith","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0460","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tim.2018.06.005","article-title":"Can \u03b2-lactam antibiotics be resurrected to combat MRSA?","volume":"27","author":"Foster","year":"2019","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0465","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41467-023-37310-5","article-title":"Modulation of MRSA virulence gene expression by the wall teichoic acid enzyme TarO","volume":"14","author":"Lu","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2025.117048_b0470","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01627-23","article-title":"Sensitizing methicillin-resistant Staphylococcus aureus (MRSA) to cefuroxime: the synergic effect of bicarbonate and the wall teichoic acid inhibitor ticlopidine","volume":"68","author":"Ersoy","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bcp.2025.117048_b0475","article-title":"Chalcogen-Varied imidazolone derivatives as antibiotic resistance breakers in Staphylococcus aureus strains","volume":"12","author":"Witek","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0480","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11033-021-06889-7","article-title":"Synergistic evaluation of Moringa oleifera extract and \u03b2-lactam antibiotic to restore the susceptibility of methicillin-resistant Staphylococcus aureus","volume":"49","author":"Vankwani","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"21","key":"10.1016\/j.bcp.2025.117048_b0485","doi-asserted-by":"crossref","first-page":"10561","DOI":"10.1080\/07391102.2021.1944911","article-title":"Molecular docking and simulation studies of flavonoid compounds against PBP-2a of methicillin-resistant Staphylococcus aureus","volume":"40","author":"Verma","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.bcp.2025.117048_b0490","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042062","article-title":"Molecular insights into an antibiotic enhancer action of new morpholine-containing 5-arylideneimidazolones in the fight against MDR bacteria","volume":"22","author":"Kaczor","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117048_b0495","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaf010","article-title":"Enhanced killing of methicillin-resistant Staphylococcus aureus with Ceftaroline or vancomycin in combination with Carbapenems","author":"Jankeel","year":"2025","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0500","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s42003-020-01313-5","article-title":"Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA","volume":"3","author":"Varela","year":"2020","journal-title":"Commun. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117048_b0505","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/molecules24030438","article-title":"5-arylideneimidazolones with amine at position 3 as potential antibiotic adjuvants against multidrug resistant bacteria","volume":"24","author":"Kaczor","year":"2019","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bcp.2025.117048_b0510","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41589-024-01688-0","article-title":"Restoring susceptibility to \u03b2-lactam antibiotics in methicillin-resistant Staphylococcus aureus","volume":"21","author":"Nguyen","year":"2025","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117048_b0515","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1039\/C4MB00319E","article-title":"Quercetin 3-O-rutinoside mediated inhibition of PBP2a: computational and experimental evidence to its anti-MRSA activity","volume":"10","author":"Rani","year":"2014","journal-title":"Mol. Biosyst."},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0520","first-page":"70","article-title":"Tea bioactive compounds as inhibitor of MRSA penicillin binding protein 2a (PBP2a): a molecular docking study","volume":"3","author":"Kalalo","year":"2020","journal-title":"Pharm. Med. J."},{"issue":"4","key":"10.1016\/j.bcp.2025.117048_b0525","doi-asserted-by":"crossref","first-page":"e01551","DOI":"10.1128\/aac.01551-24","article-title":"Mechanistic insights into the multitarget synergistic efficacy of farrerol and \u03b2-lactam antibiotics in combating methicillin-resistant Staphylococcus aureus","volume":"69","author":"Yu","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0530","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s42003-019-0667-0","article-title":"Thermosensitive PBP2a requires extracellular folding factors PrsA and HtrA1 for Staphylococcus aureus MRSA \u03b2-lactam resistance","volume":"2","author":"Roch","year":"2019","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0535","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02478-22","article-title":"Purine nucleosides interfere with c-di-AMP levels and act as adjuvants to re-sensitize MRSA to \u03b2-lactam antibiotics","volume":"14","author":"Nolan","year":"2023","journal-title":"MBio"},{"key":"10.1016\/j.bcp.2025.117048_b0540","doi-asserted-by":"crossref","first-page":"118133","DOI":"10.1016\/j.bmc.2025.118133","article-title":"Designing novel nucleoside inhibitors targeting the allosteric site of PBP2a: a strategic approach to overcome resistance in MRSA","volume":"122","author":"Yao","year":"2025","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2025.117048_b0545","doi-asserted-by":"crossref","first-page":"e00976","DOI":"10.1128\/spectrum.00976-24","article-title":"In vitro identification of underutilized \u03b2-lactam combinations against methicillin-resistant Staphylococcus aureus bacteremia isolates","volume":"12","author":"Davis","year":"2024","journal-title":"Microbiol. Spectrum"},{"key":"10.1016\/j.bcp.2025.117048_b0550","doi-asserted-by":"crossref","first-page":"130164","DOI":"10.1016\/j.bmcl.2025.130164","article-title":"Phenyl urea based adjuvants for \u03b2-lactam antibiotics against methicillin resistant Staphylococcus aureus","volume":"121","author":"Butman","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bcp.2025.117048_b0555","article-title":"Identification of Staphylococcus aureus penicillin binding protein 4 (PBP4) inhibitors","volume":"11","author":"Young","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0560","doi-asserted-by":"crossref","first-page":"e00159","DOI":"10.1128\/mmbr.00159-21","article-title":"An interplay of multiple positive and negative factors governs methicillin resistance in Staphylococcus aureus","volume":"86","author":"Bilyk","year":"2022","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2025.117048_b0565","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02727-16","article-title":"M. Chung, S. Aedo, N.C.J. Strynadka, A. Tomasz, S.S. Chatterjee, H.F. Chambers,\u00a0 High-level resistance of Staphylococcus aureus to \u03b2-lactam antibiotics mediated by penicillin-binding protein 4 (PBP4)","volume":"61","author":"Hamilton","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bcp.2025.117048_b0570","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00932-17","article-title":"PBP4 mediates \u03b2-lactam resistance by altered function","volume":"61","author":"Chatterjee","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.bcp.2025.117048_b0575","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1128\/AAC.00358-16","article-title":"PBP 4 mediates high-level resistance to new-generation cephalosporins in Staphylococcus aureus","volume":"60","author":"Chan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bcp.2025.117048_b0580","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1128\/AAC.00594-10","article-title":"A mecA-negative strain of methicillin-resistant Staphylococcus aureus with high-level \u03b2-lactam resistance contains mutations in three genes","volume":"54","author":"Banerjee","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"36","key":"10.1016\/j.bcp.2025.117048_b0585","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1021\/acs.biochem.9b00523","article-title":"BPEI-induced delocalization of PBP4 potentiates \u03b2-lactams against MRSA","volume":"58","author":"Hill","year":"2019","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.bcp.2025.117048_b0590","doi-asserted-by":"crossref","first-page":"e01210","DOI":"10.1128\/mbio.01210-24","article-title":"A MRSA mystery: how PBP4 and cyclic-di-AMP join forces against \u03b2-lactam antibiotics","volume":"15","author":"Gardner","year":"2024","journal-title":"MBio"},{"issue":"5","key":"10.1016\/j.bcp.2025.117048_b0595","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02889-23","article-title":"Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum \u03b2-lactam resistance in Staphylococcus aureus","volume":"15","author":"Lai","year":"2024","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0600","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/cb300413m","article-title":"Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to \u03b2-lactams","volume":"8","author":"Farha","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117048_b0605","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005585","article-title":"Chemical genetic analysis and functional characterization of staphylococcal wall teichoic acid 2-epimerases reveals unconventional antibiotic drug targets","volume":"12","author":"Mann","year":"2016","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0610","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/cb100269f","article-title":"Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus","volume":"6","author":"Campbell","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2025.117048_b0615","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.meegid.2018.01.018","article-title":"Evolution of methicillin-resistant Staphylococcus aureus: evidence of positive selection in a penicillin-binding protein (PBP) 2a coding gene mecA","volume":"59","author":"Zhan","year":"2018","journal-title":"Infect. Genet. Evol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0620","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10822-025-00584-6","article-title":"Elucidating allosteric signal disruption in PBP2a: impact of N146K\/E150K mutations on ceftaroline resistance in methicillin-resistant Staphylococcus aureus","volume":"39","author":"Jiao","year":"2025","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0625","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/jac\/dkv317","article-title":"PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK","volume":"71","author":"Harrison","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.bcp.2025.117048_b0630","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/AAC.04068-14","article-title":"Missense mutations in PBP2A affecting Ceftaroline Susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998","volume":"59","author":"Kelley","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.bcp.2025.117048_b0635","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00485-18","article-title":"Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus","volume":"62","author":"Lee","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bcp.2025.117048_b0640","article-title":"Unraveling the mechanisms of cefoxitin resistance in methicillin-resistant Staphylococcus aureus (MRSA): structural and molecular simulation-based insights","volume":"1\u201311","author":"Alshabrmi","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.bcp.2025.117048_b0645","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01216-19","article-title":"Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents","volume":"63","author":"Watkins","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.bcp.2025.117048_b0650","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1128\/AAC.03622-14","article-title":"PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates","volume":"58","author":"Long","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.bcp.2025.117048_b0655","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/AAC.05004-14","article-title":"Ceftobiprole- and Ceftaroline-resistant methicillin-resistant Staphylococcus aureus","volume":"59","author":"Chan","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.bcp.2025.117048_b0660","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/dkv325","article-title":"Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in african MRSA","volume":"71","author":"Schaumburg","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.bcp.2025.117048_b0665","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/omi.2021.0151","article-title":"Methicillin-resistant Staphylococcus aureus proteome response to antibiotic stress provides insights for new therapeutic strategies","volume":"25","author":"Ribeiro","year":"2021","journal-title":"OMICS"},{"issue":"7","key":"10.1016\/j.bcp.2025.117048_b0670","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/acs.jafc.9b00694","article-title":"Defying multidrug resistance! modulation of related transporters by flavonoids and flavonolignans","volume":"68","author":"Chambers","year":"2020","journal-title":"J. Agric. Food Chem."},{"issue":"4","key":"10.1016\/j.bcp.2025.117048_b0675","article-title":"New antimicrobial resistance strategies: an adaptive resistance network conferring reduced glycopeptide susceptibility in VISA","volume":"12","author":"Aguglia","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"10","key":"10.1016\/j.bcp.2025.117048_b0680","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1039\/D2MO00229A","article-title":"Nontargeted metabolomics reveals differences in the metabolite profiling among methicillin-resistant and methicillin-susceptible Staphylococcus aureus in response to antibiotics","volume":"18","author":"Liu","year":"2022","journal-title":"Mol. Omics"},{"issue":"46","key":"10.1016\/j.bcp.2025.117048_b0685","doi-asserted-by":"crossref","first-page":"27864","DOI":"10.1039\/D0RA05407K","article-title":"Multi-omics based characterization of antibiotic response in clinical isogenic isolates of methicillin-susceptible\/-resistant Staphylococcus aureus","volume":"10","author":"Jo","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.bcp.2025.117048_b0690","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2217\/fmb-2016-0021","article-title":"Drug repurposing: a new front in the war against Staphylococcus aureus","volume":"11","author":"Das","year":"2016","journal-title":"Future Microbiol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117048_b0695","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/dks405","article-title":"Is repositioning of drugs a viable alternative in the treatment of tuberculosis?","volume":"68","author":"Palomino","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"5944","key":"10.1016\/j.bcp.2025.117048_b0700","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1176667","article-title":"Antibiotics for emerging pathogens","volume":"325","author":"Fischbach","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117048_b0705","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jconrel.2024.09.028","article-title":"A new therapeutic strategy for infectious diseases against intracellular multidrug-resistant bacteria","volume":"375","author":"Wang","year":"2024","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.bcp.2025.117048_b0710","doi-asserted-by":"crossref","first-page":"e02284","DOI":"10.1128\/spectrum.02284-22","article-title":"A nonclassical mechanism of \u03b2-lactam resistance in methicillin-resistant Staphylococcus aureus and its effect on virulence","volume":"10","author":"Satishkumar","year":"2022","journal-title":"Microbiol. Spectrum"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225003132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225003132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:03:35Z","timestamp":1777392215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225003132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":142,"alternative-id":["S0006295225003132"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117048","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting MRSA penicillin-binding protein 2a: structural insights, allosteric mechanisms, and the potential of adjuvant inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117048"}}